TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Pain level assessed by VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean L* improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physician scoring improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood product transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction of discoloration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of complications following TKA
Endpoint domain: Adverse events/effects
Primary endpoint: Decline of TKA due to symptom improvement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in BMI at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of PNC service utilization
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Kidney-related event or death
Endpoint domain: Mortality/survival
Primary endpoint: PERR (Proportion of patients achieving PERR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: CRR (Proportion of patients achieving CRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: average change in BBT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MBML gain/loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: loss of marginal bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Understanding of the informed consent process
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Acceptance to sign the informed consent form
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hearing-related learning needs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of acute pancreatitis (AA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores for analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of adverse symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: ESCA score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Amount of root resorption at the apex (ARR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients who discussed PE
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diarrhea severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Abdominal/belly pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: General Severity Index (GSI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ICS attachments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Always ICS use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICS placement on the rear seat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICS placement in a rear‐facing position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: freedom from TLR
Endpoint domain: Mortality/survival
Primary endpoint: Abstinence at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: discontinuation rate of palbociclib
Endpoint domain: Adverse events/effects
Primary endpoint: Composite of total HF hospitalizations and cardiovascular death
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Simulated cuspal deflection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Staphylococcus arlettae isolation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Microbiological quality of samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: SDAI-defined remission maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FMA-LE score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean score for performance on technical and communication task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: impact of worries
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: screening distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in ICP values exceeding 22 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Reduction in out-of-range ICP values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Turnaround time for diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of 1Hr2Dx in diagnosing cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of 1Hr2Dx in diagnosing cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PIZ volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of experiencing emotional violence
Endpoint domain: Adverse events/effects
Primary endpoint: Odds of experiencing controlling behaviors
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of postoperative delirium (POD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in number of headaches
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analgesic use per month
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient preference for nasal spray
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Efficacy rating of nasal spray
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sensory perception evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total thrombus area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: dynamic knee valgus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Effect of adding bevacizumab on treatment efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for insertion of a CVC or four or more PVCs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Median overall catheter dwell time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MDS-UPDRS part III score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: AUC0-12hr
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antimicrobial activity against S.aureus, S.mutans, and C.albicans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Surface roughness (Ra) of acrylic denture and Co/Cr metallic framework
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean DSMP scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: increase of hand grip strength (HGS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Irisin serum level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatigue (FIS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Hemocompatibility profile of dialyzers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean duration for surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduction in tilt of the body’s center of mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants recovered from ARMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postintervention pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postintervention opioid use reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk factor control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: All-cause mortality within 90 days
Endpoint domain: Mortality/survival
Primary endpoint: adequate pain relief at four hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for additional analgesia at four hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Canine emergence into the oral cavity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Favorable PDC position at trial end
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Feasibility of using multiple mobile devices for T2DM self-management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cost-effectiveness of PASTA pathway
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: stress and anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: serum estradiol level on the day of oocyte triggering
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: gingival inflammatory parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of childhood diarrhoea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: FSS change at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Sleepiness (Epworth Sleepiness Scale) at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Maximal repetitions to exhaustion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum isometric voluntary muscle contraction (MVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemical pregnancy rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Likelihood of help-seeking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ultrasound scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Increased GABA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Decreased glutamate/GABA ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: treatment completion
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Cytokine concentrations (IL-1β, IL-6, TNF-α)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Postural Sway velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost of NICC compared to standard care
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Psychological flexibility (AAQII)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State mindfulness (TMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Utilization of substance use treatment services
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Grade of quadriceps tendon tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Location of tendon tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Correlation of bony avulsion with tear extent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pain at follow-up
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Patient satisfaction at 10 days postprocedure
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Baseline-normalized BBF post exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: In-stent ALG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Minimal stent area (MSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median DOPI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean area fraction of melanin forming cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time until cancer returns
Endpoint domain: Mortality/survival
Primary endpoint: Disappearance rate of symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Grade ≥ 3 adverse events related to treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Exercise of Self‐Care Agency Scale (ESCA) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Coping and Adaptation Processing Scale (CAPS) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical Dementia Rating‐Sum of Boxes score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants experiencing adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Screw placement time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression patterns of TaSPL genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regulation of inflorescence and spike development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upregulation of TaSPLs by abscisic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 28-day ventilator-free survival
Endpoint domain: Mortality/survival
Primary endpoint: EV-71 vaccine effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: savings per LEJR episode
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: shift of knee replacements to outpatient setting
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: sit-up repetitions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: push-up repetitions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: distance covered in Yo-Yo IR1 test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: therapeutic response of anogenital warts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for supplemental oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Postoperative early-relapse prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: TnT-levels variation over 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: TnT-amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean MFO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Fatmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean VO2max
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Medication appropriateness analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRB-QoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PEP (Post-Exercise Pulse)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of upper-extremity motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in total quadriceps volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: increase in triceps surae volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Disaster preparedness perceptions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Response self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mental health of children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean elicited probability of admission for infants with bronchiolitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NTS performance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: birthweight < 2500 g
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skin-to-skin thermal care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cosmetic effects
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to incident frailty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent in a pre-frailty condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Burden of comorbidity as measured by Cumulative Illness Rating Scale (CIRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total active motion of metacarpophalangeal joints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grip strength of affected finger
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood donation intention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: emotional exhaustion score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: depersonalization score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: personal accomplishment score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain medication
Endpoint domain: Adverse events/effects
Primary endpoint: Interleukin-10 (IL-10) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: LSA score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: reported likelihood of purchasing e‐cigarettes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recovery rates for moderate depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery rates for severe depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional impairment rates
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Complete epithelisation of the lateral palatal defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of occurrence of oronasal fistula
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of neuralgias
Endpoint domain: Adverse events/effects
Primary endpoint: Medical follow-up appointment return rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mammography rates at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vocal function measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global cognitive functioning improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Overall target attainment of PK/PD indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GDS stabilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Transepidermal water loss rates (TEWL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Congruence of prognosis understanding
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usefulness of communication tool
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: number of trial day occurrences of hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: painful bowel movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Subjective stress response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary sodium cut-off for predicting non-response to fluid restriction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: study feasibility
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Supplemental oxygenation requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to perform bystander CPR
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing